Author

S.C. Guba

Institution: Eli Lilly (United States)

Observed institution: Eli Lilly (United States)

OpenAlex ID: A5000790156

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

2011 · E.F. Smit, M.A. Socinski, et al. · Annals of Oncology · 29

Works count: 1

Citation count: 29

H-index: 1

I10-index: 1